UPDATED
Jan 26
New Users Please Click to Register
Renew or Upgrade your Existing  Account
UPDATE EMAIL
CHANGE PASSWORD
CHECK STATUS
CHECK PASSWORD

DISCLOSURE
BOOKMARK-HDCN
VBOOTHS
ABOUT OUR SITE
SYMPOSIA
FREE ZONE INDEX
ABSTRACTS
BY DATE
BY TOPIC
SEARCH HDCN
JOURNALS
SOCIETIES, LINKS
CLINICAL TRIALS
HYPERTENSION
DIALYSIS-CRF
CLIN NEPHROL
FREE ZONE
KEY ZONE
SEARCH

VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  eGFR
TalksbyDate   Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  

Cohen  

Berns  

  Primary Care for Nephrologists: HIV Nephropathy Flash slide/audio
(ASN Renal Week Clinical Nephrology Conference Extract, October, 2009)
Cohen: What are the nephropathies directly related to HIV infection? How have they changed in the era of HAART? What happened to the tubuloreticular inclusions? Tubular microcystic dilatation? ATN-like lesions? What about those related to complications of HIV? How does the immune complex-like lesion relate to HIV infection? What is the pathogenesis of the lupus-like lesions in HIV? What characterizes indinavir and tenofovir nephrotoxicities? Berns: What are the pitfalls of assessing GFR in patients with HIV? Why should cystatin estimates be avoided? What has follow-up data been on efficacy of ACE inhibitors and HIVAN? Under which conditions, if any, might corticosteroid treatment be considered? How does one approach TTP/TMA in HIV-infected patients? Are there any substantial access-related issues in hemodialysis patients with HIV?
(more...)


Ronco  

Ross  

Berl  

  Understanding the Kidney - Heart Connection Flash slide/audio
(ASN Renal Week Official Symposium, October, 2009)
Ronco: What is the cardiorenal syndrome? How do we define it? What are the different subtypes? How does each impact clinical outcomes? Why is an early diagnosis of AKI important? What is the role of new biomarkers in the diagnosis? Ross: How prevalent is anemia in heart failure and what are its mechanisms? What is the impact of anemia in CHF on hospitalization and survival? What do the trials of correcting anemia show? Why are the results conflicting? What should Hb targets be in view of the TREAT results? What is the RED-HF trial? Berl: What is the prognostic importance of hyponatremia in heart failure patients, and what are the benefits of correcting in it randomized, controlled trials? What is the comparable efficacy of vasopressin antagonists in SIADH and heart failure? What do randomized trials show for use of V2-antagonists in terms of hard outcomes?
(more...)


Molitch  

Wright  

Bakris  

  Controlling Diabetes Mellitus by Targeting the Kidney Flash slide/audio
(ASN Renal Week Official Symposium, October, 2009)
Molitch: What is the natural history of type 2 diabetes and how does this affect our choice of therapeutic regimens? What is the basis of GLP-1 agonists and DPP-IV inhibitors? What should the initial therapeutic intervention be? When is metformin to be used? What drugs should subsequently be added? When is insulin a preferred treatment? What are current concerns with the thiazolidinediones? What potential problems are there with each drug class in CKD? Wright: How do the kidneys handle glucose and what are the main transporters involved? What happens to patients with familial renal glucosuria, a loss-of-function mutation in SGLT-2 in terms risk of hypoglycemia and change in renal function? What drugs have an effect on SGLT-2? Bakris: What effects do SGLT-2 inhibitors have on HbA1c and on body weight? What are the potential adverse events identified in the initial trials?
(more...)


Hypertension, Cardiovascular
ARBs lower dementia risk
Rosuvastatin prevents stroke when CRP high
Niacin enhances HDL endothelial effects
Obesity worsens metabolic impact of anti-HTN drugs
CKD, ESRD
Mild blood elevations and CKD in kids
Tissue AGE in dialysis patients
CHOIR results differ by comorbidity
Better HBV vaccine for ESRD
Rapid ID of bacteria in blood cultures
Clinical Nephrology
Retinopathy and early CKD in Alport syndrome
Glomerular density and IGAN prognosis
Novel B cell therapeutic targets in GN
Role of rituximab in GN
Oral hydrogen water prevents chronic allograft nephropathy
MMF and CyA similar efficacy for lupus class V induction therapy




ASN Renal Week 2009
now in MP3
AUDIOFILE LIST (ASN Renal Week 2009)
(37 talks)
Management of Common Problems in Polycystic Kidney Disease
K. Ty Bae, A. B. Chapman and V. E. Torres

Literature Review: ICU Nephrology and Critical Care Medicine
K. D. Liu, and A. J. Tolwani

Hypertensive Nephrosclerosis: Cause or Consequence of Hypertension
R. D. Toto, B. I. Freedman, J. Lewis, and F. C. Luft

Hepatitis C and Renal Disease
C. L. Berg, R. D. Bloom, R. S. Brown

Are We Making Progress in Vascular Access?
A. S. Yevzlin, A. Asif, D. M. Hentschel, and A. Q. Urbanes

Reducing Health Disparities in CKD
M. H. Chin, P. W. Eggers, W. M. McClellan, and N. R. Powe

Primary Care for Nephrologists: HIV Nephropathy
P. L. Kimmel, A.H. Cohen, J. S. Berns, and S.J. Tomlanovich

Peritoneal Dialysis: A Bright Past and Unknown Future
I. Teitelbaum, F. O. Finkelstein, P. G. Blake, and M. D. Faber

Desperately Seeking a Donor: Difficult Choices in Kidney Donation
F. L. Delmonico, A. B. Leichtman, J. A. Fishman, and D. L. Segev

Cardiorenal Syndrome
C. Ronco, A. S. Maisel, and A. A. House




Hypertension, Cardiovascular:
Metabolic syndrome in CRIC

Dialysis, CKD:
P-cresol and CV risk; Pi binders and outcome in early CKD; Early vs. delayed ESA in early CKD; Hematide results; IV iron and platelets; 24-D levels and risk; AMG223 to control Pi; Alk phos and mortality with normal GFR; Lanthanum, CAC and endothelial fxn; FGF23 and bone density; heart rate variability as a risk factor; troponin T to diagnose MI in CKD.

Clinical Nephrology:
Cystatin C in the ICU; hyponatremia epidemiology, osteoporosis, equation to estimate saline infusion rate; mortality; Fractional excretion of urate; Astrocyte death during hyponatremia correction; NGAL and other urinary biomarkers; Anti-GBM antibody chronology; Febuxostat vs. allopurinol; Rituximab, tacrolimus for MMC; Rituximab in nephrotic syndrome; Glycosylation of IgA1 in IGAN; Lupus: rebiopsy; rituximab and MMF for relapses; POCY utility; geographical variation in response to MMF; Diabetic nephropathy without albuminuria in kids; New therapies for ANCA vasculitis.  (more...)


    Hit reload / refresh
Login stopped working? Bouncing email logins suspended.
Slide/audio problem when lectures played with legacy options using Windows Media or Real Player.
HDCN_RSS  Click on RSS for details of each news story.
Updated: February 09, 2010 (Feb09)
Feb09 Even mild hypokalemia in heart failure patients with early-stage CKD associated with increased mortality.
Feb08 What is "third-hand smoke" and why is it potentially dangerous?
Feb08 AMAG safety update on adverse effects in patients taking Ferraheme
Feb08 Speed dating model used to match physicians with patients.
Feb08 TERC and telomere length linked to biologic age in humans.
Feb08 Barley, beer (esp. pale ale), orthosilicic acid, and bone health
Feb04 ANNA anounces its new elected officers for the coming year.
Feb04 Who will provide unreimbursed dialysis to immigrant dialysis patients in Atlanta?
Feb04 Metabolism across mammals is a function of body weight to the 2/3 power and not to the 3/4.
Feb04 USRDS presentations at ASN Renal Week 2009
Feb04 New metaanalysis debunks link between saturated fat intake and heart disease.
Feb03 Why changing the gut microbiota with antibiotics may have adverse effects.
Feb03 Nordic Medcom AB to distribute NxStage hemodialysis system in Scandinavia.
Feb03 NEJM: Many people in a coma are not really in a coma - willful modulation of brain activity.
Feb01 CMS issues new guidelines for adequacy, infection, and access reporting.
Feb01 Serious liver disorder associated with didanosine (drug used to treat HIV) use
Jan29 Class I recall issued for Aquarius hemodialysis machine made by Edwards and distributed by Baxter.
Jan29 Spontaneous remission in 34% of patient with idiopathic membranous GN treated conservatively.
Jan29 Overweight elderly live longer.
Jan27 ASH 25th Annual Scientific Meeting to be held May 1-4, 2010 in New York City.
General Advances Emphasis
archive
Novel B-cell therapeutic targets in transplantation and immune- mediated glomerular diseases
Vincenti, Cohen, and Appel discuss not only rituximab but other novel B-cell therapies and their efficacy against lupus, ANCA, IgA, FSGS, and other related conditions; in the January issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

Role of rituximab therapy in glomerulonephritis
Jayne reviews rituximab efficacy in ANCA vasculitis, SLE, and membranous GN, in the January issue of the J Am Soc Nephrol (CJASN) (more...)

Metabolic syndrome in solid organ transplantation
Sharif discusses pathophysiology, risk factors, effects on graft and patient survival, as well as implicated drugs and avoidance strategies; in the January issue of the Am J Transplant. (more...)

The role of the mammalian target of rapamycin (mTOR) in renal disease
Lieberthal and Levine review how mTOR is involved in recovery from renal injury, diabetic nephropathy, cystic diseases of the kidney, and renal carcinoma; in the December issue of the J Am Soc Nephrol (CJASN) (more...)

Cardiorenal syndrome in acute decompensated heart failure
Sarraf, Maoumi and Schrier review pathogenesis and various possible treatments, in the December issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence
Thomas and Jaber look critically at the data for use of hemodiafiltration and other convective therapies in both acute and chronic situations; in the Nov/Dec issue of Seminars in Dialysis. (more...)

Interstitial cystitis: an unsolved enigma
Moutzouris and Falagas review the diagnosis of IC, the role of specific and supportive therapies, and directions for future research, in the November issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

MASTering Treg function to promote tolerance
Levings and Thomson discuss a paper by Noelle in which rejection of skin grafts was treated by activation of mast cells in a T-cell mediated process; in the October issue of the Am J Transplant. (more...)

The Declaration of Istanbul: Review and commentary by the American Society of Transplant Surgeons Ethics Committee and Executive Committee
Reed et al talk about the issues in applying the principles in this declaration to the North American setting; in the November issue of the Am J Transplant. (more...)

Encapsulating peritoneal sclerosis: Importance to the hemodialysis practitioner
In this Trainee Forum, Perl, Bargman and Chan tell us why peritoneal sclerosis is such an important issue to long-term PD and what we can do about it; in the October 2009 issue of the Hemodial Int (more...)

Mineralocorticoid receptor blockers and chronic kidney disease
Jain and colleagues review the scientific basis for renoprotection by blocking mineralocorticoid receptors, including a discussion of risks and benefits of current treatments; in the October issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

450+
  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

Boots on the Ground: Do We Have Enough Personnel to Fight the Battle Against CKD? (Wish and Piraino)
Controversies in Vascular Access (Asif and Urbanes)
ASDIN: 5th Annual Scientific Meeting, February, 2009.
Nephrology Quiz and Questionnaire: Fluids and Electrolyte and Glomerular Disorders (Palmer and Pusey)
Primary Care in Nephrology: Preoperative Risk Assessment and Management of Glycemic Control (Golper and Mordes)
IgA Nephropathy: Time to Change Our Approach? (Feehally and Hogg)
Advances in CKD 2009 (various speakers)
CKD Care and Your Practice Culture: Improve Your Performance! (Maddux, Molony, Kliger, Blaser, et al)
The Sexual Life Cycle of Women with CKD (Yao, Hou, Kurella-Tamura)
Resistant Hypertension: A Challenge for the Nephrologist (Campese and Steigerwalt)
New Frontiers in Phosphorus Homeostasis in CKD (Quarles, Wolf)
Care of the Chronic Kidney Disease Patient (Campbell, Berns, Batlle)
Managing CKD-MBD through the Disease Continuum (Thadhani, Kestenbaum)
Restoring Balance: New Therapeutic Approaches to Acute Decompensated Heart Failure (Goldberg, Schrier, and Gheorghiade)
The Year in Nephrology: Hypertension and Metabolic Renal Syndrome (Griffin and Beddhu)
Nephrology Roundtable: Glucose Transport and Targets for Intervention (De Zeeuw, Wright)
Acute Renal Replacement Therapy (Palevsky)
The ESA Controversy: The Role of Intravenous Iron (Ganz, Agarwal, Besarab)
Shades of Grey: Key Questions in the Future of Treatment for CKD-Related Anemia (Schmidt, Toto, Norris)
Gammopathies and the Kidney and Thrombotic Microangiopathy (Falk)
Ischemic Nephropathy: Diagnosis and Management (Textor)
Disorders of Calcium and Phosphorus Metabolism (Wolf)
FREE
Managing Anemia in Chronic Kidney Disease: The Benefits to Patients (Schira)
  Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)
Nephrology Quiz and Questionnaire: Fluid and Electrolyte and Glomerulonephritis Cases (Emmett and Radhakrishnan)
Controversies in Diagnosis and Treatment of Atherosclerotic Renovascular Disease (Textor and Dworkin)
FREE
What You Can Teach Your Team About Chronic Kidney Disease-Related Mineral Bone Disorder (CKD-MBD) (Schmidt and Senft)
New Insights, Treatments, and Management Strategies for ADPKD (Chapman and Calvet)
FREE
Stabilizing Hemoglobin Levels: What's New in IV Iron and Anemia Management? (Fishbane, VanBuskirk, Larson)
Novel Therapeutics for Fluid and Electrolyte Disorders (Verbalis and Palmer)
DILEMMAS IN THE TREATMENT OF GLOMERULAR DISEASE:
Treatment of Frequently Relapsing/Steroid Dependent Minimal Change Disease (Hogg);
Evaluation and Treatment Approach to Steroid-Resistant Primary FSGS in Adults (Meyrier).
Congestive Heart Failure: A Nephrologist's Disease? (Murray)
AKI Therapeutics: From Bench to Commercialisation (Molitoris)
FREE
New Perspectives on the Progression of Coronary Artery Calcification and Patient Outcomes in Chronic Kidney Disease (Qunibi, Szczech)
Renal Disease and the Metabolic Syndrome (Muntner and Fried)
Nephrolithiasis (Worcester and Lieske)
The Genetics of FSGS (Hildebrandt and Kaskel)
Primary Care Issues in Nephrology: Peripheral Vascular Disease: Assessments and Approaches to Care (Froehlich); Rheumatology for Nephrologists (Kay).
Achieving Control: Optimizing the Management of CKD-Anemia (Nissenson, Fishbane, Germain, and Provenzano)
Mycophenolate in Lupus and Non-Glomerular Renal Diseases (Shaw and Appel)
  ASDIN Annual Meeting 2008
  RPA Annual Meeting 2008
  Advances in CKD 2008 (RRI 10th Annual International Dialysis Symposium
Management of Hyperphosphatemia in Patients with ESRD: A New Direction for Treatment in 2008 (Qunibi and Nolan)
Aldosterone: New Insights in Kidney Health and Disease (Calhoun and Rosenberg)
Pre-ESRD and Mineral Metabolism (Martin and Moe)
New Insights into Common Problems After Kidney Transplantation (Kasiske and Weisinger)
Challenges and Opportunities in the Treatment of Hyperuricemia and Gout (Terkeltaub, Rich, Feig)
New Treatments for Diabetes Mellitus: Implications for Clinicians (Nelson and Bakris)
The Aging Kidney (Fliser and Aronoff)
Phosphate Binders in CKD: An Update on Treatment Outcomes and Future Directions (London, Langman, Ketteler)
Challenges in Volume Management. Optimizing Care in Patients with Heart Failure and Renal Dysfunction (Burnett, Fowler, Gheorghiade)
Cardiovascular Disease in End Stage Renal Disease Patients (Henrich)
Contrast Media and CKD: What You Should Know About Contrast-Induced Nephropathy and Nephrogenic Systemic Fibrosis (Persson, Knopp, Perazella)
New Developments in Anemia Management in Chronic Kidney Disease (Roy, Besarab, Amerling, Berns)
The Cystic Diseases (Bennett)
Navigating the Erythropoietin Stimulating Agent Landscape in CKD-Related Anemia (Berns, Provenzano, Szczech)
Critical Care Nephrology (Murray)
FREE
Chronic Kidney Disease - Mineral Bone Disorder (Arruda, Snavely)
Electrolyte/Acid-Base Emergencies in the ICU (Palmer)
Nocturnal and Frequent Dialysis: Are These the Preferred Therapies for Patients with Cardiovascular Disease?
FREE
Updating Practices in an Evolving IV Iron and Anemia Environment: Practical Solutions. A New Anemia Treatment Paradigm in Favor of the Patient (Easom, Juergensen, Amerling)
Sudden Death in Hemodialysis Patients: Epidemiology
Diabetes and Non-insulin Management in CKD
Obesity and Outcomes in Dialysis Patients
Is Obesity a Risk Factor for the Development And Progression of Chronic Kidney Disease?
FREE
Standards: The Basis of Care to Manage the Patient with Complications of Chronic Kidney Disease Leading to Cardiovascular Disease (Burrows-Hudson, Headley, Campoy)
FREE
Achieving and Maintaining a Phosphate Balance in the Patient With CKD (Mathers)
Cocaine and Chronic Kidney Injury
Proton Pump Inhibitors and the Kidney: Critical Review
Characteristics of the Long-Term Peritoneal Dialysis Patient
Prospects and Challenges for a Staphylococcal Vaccine
Alternatives to Vancomycin in the Treatment of Gram-Positive Cocci
Overview of Catheter Lock Solutions
Are ACE inhibitors and ARBs Essential to Renoprotection? Debate.
Early Anemia Management: Incorporating New Evidence Into Appropriate Treatment Strategies for Chronic Kidney Disease
3rd Annual Scientific Meeting of the ASDIN. April, 2007.
Improving Efficiency in the Nephrologist's Office. RPA Annual Meeting (2007)
RRI Ninth International Conference on Dialysis, January, 2007. Part Four
Bone and Mineral Metabolism in CKD: Medical Crossfire
RRI Ninth International Conference on Dialysis, January, 2007. Part Three
Fluid Dysregulation: Disturbances and Management
RRI Ninth International Conference on Dialysis, January, 2007. Part Two
Inflammation in CKD: Biomarkers, Morbidity and Therapy
Managing CMV Infections in Transplantation
RRI Ninth International Conference on Dialysis, January, 2007. Part One
Disorders of Sodium Metabolism: Case Presentations
The CKD that Follows Renal Transplantation: How to Best Manage these Patients?
Transplant Biopsy
The New KDOQI Guidelines for Anemia; Debate: Should an Upper Hgb Limit be Set and What Should it Be?
Calcimimetics: Monotherapy for Secondary Hyperparathyroidism?
Lupus Nephritis: Defining and Treating Renal Flares
Secondary Hypertension, including Chronic Kidney Disease
New, Tri-Partite Approach to Anemia
Magnesium Balance: Hypomagnesemia and Hypermagnesemia
Pathogenesis and Management of Cardiovascular Disease (CVD) in Chronic Kidney Disease
Transplantation: Medical and Immunosuppressive Management
  Using Technology to Improve the Quality of Care (target audience: technicians)
more...













 
Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

Warning-Disclaimer:
The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented in this journal/server.

Copyright statement:
Copyright - 1995 - 2008 by Medtext, Inc. All rights reserved. No part of the material on this journal/server may be reproduced in any form or by any electronic or mechanical means, including information storage and retrieval systems, without permission in writing from the publisher, except by a reviewer who may quote brief passages in a review.

Published by Medtext, Inc., Burr Ridge, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com

96 97 98 99